Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 3 5Phase 2 3Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Hematologic Neoplasms 2Xerostomia Due to Radiotherapy (Disorder) 1Ulcer 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Seizures 1Renal Insufficiency 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Kidney Failure, Chronic 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Glioma 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms 1Advanced/Metastatic Solid Tumors 12019 Novel Coronavirus 1

Interventions

pembrolizumab 24Radiotherapy 21Cisplatin 21Cetuximab 13Carboplatin 11Paclitaxel 8Nivolumab 8durvalumab 7Radiotherapy, Intensity-Modulated 6Docetaxel 6Fluorouracil 5Cyclophosphamide 5zalutumumab 4Everolimus 4Amifostine 4spartalizumab 3fludarabine 3epacadostat 3cemiplimab 3Ipilimumab 3Immune Checkpoint Inhibitors 3Gefitinib 3Filgrastim 3Erlotinib Hydrochloride 3Celecoxib 3Capecitabine 3selpercatinib 2palbociclib 2fludarabine phosphate 2bintrafusp alfa protein, human 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Head and Neck Neoplasms × Standard of Care × Clear all
NCT05664906 2022-12-27

Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients

Chinese University of Hong Kong

Phase 1/2 Unknown
40 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡